Revolutionizing Drug Discovery: Quantum-Based Machine Learning Simulation for Tomorrow's Medicine
Abstract
The pharmaceutical industry has reached a pivotal moment, where the integration of quantum computing and machine learning stands to redefine the drug discovery process. This article explores the implications of Quantum-Based Machine Learning Simulation (QMLS) and its potential to shape the future of medicine. We delve into the convergence of quantum computing, artificial intelligence, and drug development, highlighting the promising breakthroughs and challenges ahead.
How strong is the evidence?
Evidence Hub reads this as a preprint, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- In silico toxicology protocols
- QM7-X, a comprehensive dataset of quantum-mechanical properties spanning the chemical space of small organic molecules
- Quantum Informed Machine-Learning Potentials for Molecular Dynamics Simulations of CO2's Chemisorption and Diffusion in Mg-MOF-74
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
- The computational power of the human brain
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.